LINCOLN, Neb., Nov. 17, 2020 — NEOGEN Corporation announced today its partnership with Transnetyx, Inc., to collaborate on distribution and advancement of the miniMUGA genotyping array (Mouse Universal Genotyping Array) through Transnetyx’s wide-reaching footprint in the model organism community.
Powered by NEOGEN Genomics, the miniMUGA array was developed by researchers at the University of North Carolina Chapel Hill. The panel contains over 10,000 markers that can be used to determine genetic background in over 241 inbred mice including classical, wild-derived and recombinant inbred lines. Its focus is to provide a valuable platform for genetic QC and vital new tool to increase rigor and reproducibility of mouse biomedical research.
“We are excited to partner with Transnetyx for their innovative distribution and quality customer service for the miniMUGA genotyping array,” said Marylinn Munson, vice president of NEOGEN Genomics. “I see the biomedical research community as a whole will be the biggest beneficiary of this partnership, as they can now take full advantage of the combined expertise of Transnetyx, a service leader in the mouse industry and NEOGEN’s expertise in the development of genomic solutions.”
Transnetyx was founded in 2000 and launched the world’s first fully automated genotyping system for detecting transgenic, knockout, knock-in, SNP and CRISPR mutations in animal research models. Since the first test in 2004, Transnetyx has processed more than 20 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy. Aligning with the mission to serve research and save time, Transnetyx has introduced a variety of service offerings, including Colony Management software and Genetic Monitoring.
“We’re thrilled to be able to offer the biomedical research community a comprehensive and affordable solution for testing the genetic background of their mouse models,” said Bob Bean, president and CEO of Transnetyx. “Transnetyx prides itself on partnering with researchers to save them time and increase the efficiency of their work. The miniMUGA array will provide Transnetyx customers with a new tool to support them as they work to ensure the rigor and reproducibility of their research. MiniMUGA is one more tool we can offer to help serve the research community.”
“The miniMUGA product is the fourth iteration of our murine genotyping portfolio. However, miniMUGA does differ from our previous offerings, in that it was specifically designed for quality control applications,” said Ben Pejsar, NEOGEN Genomics product manager for North America research and academic communities. “Despite the importance of genetics for mouse research, genetic quality control was lacking an informative and cost-effective screening tool. The miniMUGA product gives the research community a much-needed solution.”
About Transnetyx. Memphis-based Transnetyx is a research support company dedicated to serving research and saving time by providing automated, accurate solutions for testing critical to research. Transnetyx’s mission is to provide faster, more accurate and more affordable methods to help support responsible, reproducible research. Transnetyx has the technology and processes in place to provide faster, easier and more accurate results to biomedical researchers worldwide. By optimizing resources, Transnetyx has paved the way for research to advance and deeper understandings to emerge. For more information, visit www.transnetyx.com.
About NEOGEN. NEOGEN Corporation (NASDAQ: NEOG) develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. NEOGEN’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants. To learn more about NEOGEN Genomics visit https://genomics.NEOGEN.com/en.